Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care

NCT00440687 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Fluticasone 500mcg BD via accuhaler or identical placebo

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]